Absence of high-affinity adenosine 3',5'-monophosphate binding sites from the cytosol of three hepatic-derived cell lines.
D000249:Adenosine Monophosphate / Q000494:pharmacology; D000818:Animals; D001665:Binding Sites; D001667:Binding, Competitive; D003994:Bucladesine / Q000494:pharmacology; D002460:Cell Line; D002850:Chromatography, Gel; D002852:Chromatography, Ion Exchange; D000242:Cyclic AMP / Q000378:metabolism*; D006152:Cyclic GMP / Q000494:pharmacology; D003600:Cytosol / Q000187:drug effects / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D007292:Inosine Nucleotides / Q000494:pharmacology; D007700:Kinetics; D008099:Liver / Q000201:enzymology / Q000378:metabolism*; D008297:Male; D009712:Nucleotides, Cyclic / Q000494:pharmacology; D011485:Protein Binding; D011494:Protein Kinases / Q000378:metabolism; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects; D013010:Sonication; D014316:Tritium
D007292:Inosine Nucleotides; D009712:Nucleotides, Cyclic; D011955:Receptors, Drug; D014316:Tritium; D000249:Adenosine Monophosphate; D003994:Bucladesine; D000242:Cyclic AMP; D011494:Protein Kinases; D006152:Cyclic GMP